申请人:LILLY CO ELI
公开号:WO2000000201A1
公开(公告)日:2000-01-06
A class of novel pyrrolo[2,3-d]pyrimidine compounds is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of diseases such as septic shock.